Skip to content
GenoLensGenoLens

ARSG

Chr 17q24.2

arylsulfatase G

Aliases:
KIAA1001
MANE:
ENST00000621439.5

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Lysosomal storage disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Retinal disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Monogenic hearing loss

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Usher syndrome, type 4

    0.69
  • neurodegenerative disease

    0.41
  • Usher syndrome type 3

    0.37
  • Usher syndrome

    0.34
  • diabetes mellitus

    0.17
  • Retinal dystrophy

    0.14
  • Limb dystonia

    0.09
  • cervical carcinoma

    0.06
  • renal coloboma syndrome

    0.03
  • Senior-Loken syndrome

    0.03

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Arylsulfatase G

Displays arylsulfatase activity at acidic pH towards artificial substrates, such as p-nitrocatechol sulfate and also, but with a lower activity towards p-nitrophenyl sulfate and 4-methylumbelliferyl sulfate (PubMed:18283100, PubMed:29300381). Catalyzes the hydrolysis of the 3-sulfate groups of the N-sulfo-D-glucosamine 3-O-sulfate units of heparin (PubMed:22689975)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.